Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001387131-19-002012
Filing Date
2019-03-18
Accepted
2019-03-18 16:14:22
Documents
62
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT tnxp-10ka_123118.htm 10-K/A 79005
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-01.htm EX-23.01 4740
  Complete submission text file 0001387131-19-002012.txt   3540978

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT tnxp-20181231.xml EX-101.INS 762355
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20181231.xsd EX-101.SCH 49232
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnxp-20181231_cal.xml EX-101.CAL 56824
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnxp-20181231_def.xml EX-101.DEF 192628
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20181231_lab.xml EX-101.LAB 382187
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20181231_pre.xml EX-101.PRE 279753
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36019 | Film No.: 19688367
SIC: 2834 Pharmaceutical Preparations